References
- Ashtankar, H. J., & Talapalliwar, M. R. (2017). Felt need and treatment-seeking barriers among substance abusers in urban slum area in Central India. Indian Journal of Psychological Medicine, 39(4), 436–440. https://doi.org/https://doi.org/10.4103/0253-7176.211760
- Azbel, L., Rozanova, J., Michels, I., Altice, F. L., & Stöver, H. (2017). A qualitative assessment of an abstinence-oriented therapeutic community for prisoners with substance use disorders in Kyrgyzstan. Harm Reduction Journal, 14(1), 43.https://doi.org/https://doi.org/10.1186/s12954-017-0168-8
- Bailey, K. P. (2004). Pharmacological treatments for substance use disorders. Journal of Psychosocial Nursing and Mental Health Services, 42(8), 14–20. https://doi.org/https://doi.org/10.3928/02793695-20040801-03
- Balaji, D., Mlunde, L. B., Tran, O. C., Lambdin, B., Mbwambo, J., Nyandindi, C., Matiko, E., Copenhaver, M., & Douglas Bruce, R. (2017). First report of gender based violence as a deterrent to methadone access among females who use heroin in Dar es Salaam, Tanzania. AIDS Behav, 21(7), 2093–2100. https://doi.org/https://doi.org/10.1007/s10461-016-1529-0
- Barman, R., Mahi, R., Kumar, N., C Sharma, K., Singh Sidhu, B., Singh, D., & Mittal, N. (2011). Barriers to treatment of substance abuse in a Rural Population of India. The Open Addiction Journal, 4(1), 65–71. https://doi.org/https://doi.org/10.2174/1874941001104010065
- Benegal, V., Chand, P. K., & Obot, I. S. (2009). Packages of care for alcohol use disorders in low-and middle-income countries. PLoS Medicine, 6(10), e1000170. https://doi.org/https://doi.org/10.1371/journal.pmed.1000170
- Binnal, A., Rajesh, G., Ahmed, J., & Denny, C. (2016). Determinants of smokeless tobacco consumption and its cessation among its current users in India. Journal of Clinical and Diagnostic Research, 10(10), ZC103–ZC109. https://doi.org/https://doi.org/10.7860/JCDR/2016/22704.8690
- Bojko, M. J., Mazhnaya, A., Makarenko, I., Marcus, R., Dvoriak, S., Islam, Z., & Altice, F. L. (2015). “Bureaucracy & beliefs”: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine. Drugs (Abingdon, England), 22(3), 255–262. https://doi.org/https://doi.org/10.3109/09687637.2015.1016397
- Bojko, M. J., Mazhnaya, A., Marcus, R., Makarenko, I., Islam, Z., Filippovych, S., Dvoriak, S., & Altice, F. L. (2016). The future of opioid agonist therapies in Ukraine: A qualitative assessment of multilevel barriers and ways forward to promote retention in treatment. Journal of Substance Abuse Treatment, 66, 37–47. https://doi.org/https://doi.org/10.1016/j.jsat.2016.03.003
- Butelman, E. R., & Kreek, M. J. (2017). Medications for substance use disorders (SUD): Emerging approaches. Expert Opinion on Emerging Drugs, 22(4), 301–315. https://doi.org/https://doi.org/10.1080/14728214.2017.1395855
- Chakrapani, V., Kamei, R., Kipgen, H., & Kh, J. K. (2013). Access to harm reduction and HIV-related treatment services inside Indian prisons: Experiences of formerly incarcerated injecting drug users. International Journal of Prisoner Health, 9(2), 82–91. https://doi.org/https://doi.org/10.1108/17449201311326952
- Clever, S. L., Jin, L., Levinson, W., & Meltzer, D. O. (2008). Does doctor–patient communication affect patient satisfaction with hospital care? Results of an analysis with a novel instrumental variable. Health Services Research, 43(5p1), 1505–1519. https://doi.org/https://doi.org/10.1111/j.1475-6773.2008.00849.x
- Cooke, A., Saleem, H., Hassan, S., Mushi, D., Mbwambo, J., & Lambdin, B. (2019). Patient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention. Addiction Science & Clinical Practice, 14(1), 3.https://doi.org/https://doi.org/10.1186/s13722-019-0133-9
- Cumming, C., Troeung, L., Young, J. T., Kelty, E., & Preen, D. B. (2016). Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis. Drug Alcohol Depend, 168, 263–273. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2016.10.001
- Cunningham, J. A., Sobell, L. C., Sobell, M. B., Agrawal, S., & Toneatto, T. (1993). Barriers to treatment: Why alcohol and drug abusers delay or never seek treatment. Addictive Behaviors, 18(3), 347–353. https://doi.org/https://doi.org/10.1016/0306-4603(93)90036-9
- Degenhardt, L., Bharat, C., Glantz, M. D., Sampson, N. A., Scott, K., Lim, C. C. W., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Andrade, L. H., Bromet, E. J., Bruffaerts, R., Bunting, B., de Girolamo, G., Gureje, O., Haro, J. M., Harris, M. G., He, Y., de Jonge, P., … Kessler, R. C. (2019). The epidemiology of drug use disorders cross-nationally: Findings from the WHO’s World Mental Health Surveys. The International Journal on Drug Policy, 71, 103–112. https://doi.org/https://doi.org/10.1016/j.drugpo.2019.03.002
- Degenhardt, L., Chiu, W.-T., Sampson, N., Kessler, R. C., Anthony, J. C., Angermeyer, M., Bruffaerts, R., de Girolamo, G., Gureje, O., Huang, Y., Karam, A., Kostyuchenko, S., Lepine, J. P., Mora, M. E. M., Neumark, Y., Ormel, J. H., Pinto-Meza, A., Posada-Villa, J., Stein, D. J., Takeshima, T., & Wells, J. E. (2008). Toward a global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the WHO World Mental Health Surveys. PLoS Medicine, 5(7), e141. https://doi.org/https://doi.org/10.1371/journal.pmed.0050141
- Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., Hall, W. D., Freedman, G., Burstein, R., Johns, N., Engell, R. E., Flaxman, A., Murray, C. J., & Vos, T. (2013). Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010. The Lancet, 382(9904), 1564–1574. https://doi.org/https://doi.org/10.1016/S0140-6736(13)61530-5
- Deryabina, A., & El-Sadr, W. M. (2017). Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators. Drug Alcohol Depend, 179, 180–186. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2017.07.002
- Donroe, J. H., & Tetrault, J. M. (2018). Narrowing the treatment gap in managing opioid use disorder. CMAJ : Canadian Medical Association Journal = Journal de L’Association Medicale Canadienne, 190(9), E236–E237. https://doi.org/https://doi.org/10.1503/cmaj.180209
- Douaihy, A. B., Kelly, T. M., & Sullivan, C. (2013). Medications for substance use disorders. Social Work in Public Health, 28(3–4), 264–278. https://doi.org/https://doi.org/10.1080/19371918.2013.759031
- Dua, T., Barbui, C., Clark, N., Fleischmann, A., Poznyak, V., van Ommeren, M., Yasamy, M. T., Ayuso-Mateos, J. L., Birbeck, G. L., Drummond, C., Freeman, M., Giannakopoulos, P., Levav, I., Obot, I. S., Omigbodun, O., Patel, V., Phillips, M., Prince, M., Rahimi-Movaghar, A., … Saxena, S. (2011). Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: Summary of WHO recommendations . PLoS Medicine, 8(11), e1001122. https://doi.org/https://doi.org/10.1371/journal.pmed.1001122
- Evans-Lacko, S., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Benjet, C., Bruffaerts, R., Chiu, W. T., Florescu, S., de Girolamo, G., Gureje, O., Haro, J. M., He, Y., Hu, C., Karam, E. G., Kawakami, N., Lee, S., Lund, C., Kovess-Masfety, V., Levinson, D., … Thornicroft, G. (2018). Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: Results from the WHO World Mental Health (WMH) Surveys. Psychological Medicine, 48(9), 1560–1571. https://doi.org/https://doi.org/10.1017/S0033291717003336
- Farag, M., NandaKumar, A. K., Wallack, S., Hodgkin, D., Gaumer, G., & Erbil, C. (2012). The income elasticity of health care spending in developing and developed countries. International Journal of Health Care Finance and Economics, 12(2), 145–162. https://doi.org/https://doi.org/10.1007/s10754-012-9108-z
- GBD 2016 Alcohol and Drug Use Collaborators. (2018). The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet. Psychiatry, 5(12), 987–1012. https://doi.org/https://doi.org/10.1016/S2215-0366(18)30337-7
- Huskamp, H. A., Busch, A. B., Souza, J., Uscher-Pines, L., Rose, S., Wilcock, A., Landon, B. E., & Mehrotra, A. (2018). How is telemedicine being used in opioid and other substance use disorder treatment?Health Affairs (Project Hope), 37(12), 1940–1947. https://doi.org/https://doi.org/10.1377/hlthaff.2018.05134
- Isaakidis, P., Rangan, S., Pradhan, A., Ladomirska, J., Reid, T., & Kielmann, K. (2013). ‘I cry every day’: Experiences of patients co-infected with HIV and multidrug-resistant tuberculosis. Tropical Medicine & International Health: TM & IH, 18(9), 1128–1133. https://doi.org/https://doi.org/10.1111/tmi.12146
- Kermode, M., Songput, C. H., Sono, C. Z., Jamir, T. N., & Devine, A. (2012). Meeting the needs of women who use drugs and alcohol in North-east India—A challenge for HIV prevention services. BMC Public Health, 12(1), 825. https://doi.org/https://doi.org/10.1186/1471-2458-12-825
- Klein, J. W. (2016). Pharmacotherapy for substance use disorders. The Medical Clinics of North America, 100(4), 891–910. https://doi.org/https://doi.org/10.1016/j.mcna.2016.03.011
- Kruk, M. E., Chukwuma, A., Mbaruku, G., & Leslie, H. H. (2017). Variation in quality of primary-care services in Kenya, Malawi, Namibia, Rwanda, Senegal, Uganda and the United Republic of Tanzania. Bulletin of the World Health Organization, 95(6), 408–418. https://doi.org/https://doi.org/10.2471/BLT.16.175869
- Kumar, S., Gupte, H. A., Isaakidis, P., Mishra, J. K., Munjattu, J. F. (2018). “They don’t like us….”: Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study…. PloS One, 13(8), e0203262. https://doi.org/https://doi.org/10.1371/journal.pone.0203262
- Lago, L., Glantz, M. D., Kessler, R. C., Sampson, N. A., Al-Hamzawi, A., Florescu, S., Moskalewicz, J., Murphy, S., Navarro-Mateu, F., Torres de Galvis, Y., Viana, M. C., Xavier, M., & Degenhardt, L. (2017). Substance dependence among those without symptoms of substance abuse in the World Mental Health Survey. International Journal of Methods in Psychiatric Research, 26(3), e1557. https://doi.org/https://doi.org/10.1002/mpr.1557
- Lee, J., Kresina, T. F., Campopiano, M., Lubran, R., & Clark, H. W. (2015). Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care. BioMed Research International, 2015, 137020. https://doi.org/https://doi.org/10.1155/2015/137020
- Lohit, K., Kulkarni, C., & Galgali, R. B. (2016). Factors influencing adherence to anti-craving medications and drinking outcomes in patients with alcohol dependence: A hospital-based study. Journal of Pharmacology and Pharmacotherapeutics, 7(2), 72–79. https://doi.org/https://doi.org/10.4103/0976-500X.184770
- Luitel, N. P., Jordans, M. J. D., Kohrt, B. A., Rathod, S. D., & Komproe, I. H. (2017). Treatment gap and barriers for mental health care: A cross-sectional community survey in Nepal. PloS One, 12(8), e0183223. https://doi.org/https://doi.org/10.1371/journal.pone.0183223
- Lv, Z., & Zhu, H. (2014). Health care expenditure and GDP in African countries: Evidence from semiparametric estimation with panel data. TheScientificWorldJournal, 2014, 905747. https://doi.org/https://doi.org/10.1155/2014/905747
- Mackinnon, N., Bhatia, U., & Nadkarni, A. (2019). The onset and progression of alcohol use disorders: A qualitative study from Goa, India. Journal of Ethnicity in Substance Abuse, 18(1), 89–102. https://doi.org/https://doi.org/10.1080/15332640.2017.1326863
- Maiti, T., Das, S., Ramasamy, A., Stanley Xavier, A., Kumar Behera, S., & Selvarajan, S. (2020). An overview on medication-assisted treatment (MAT) for opioid dependence. Journal of Opioid Management, 16(2), 141–149. https://doi.org/https://doi.org/10.5055/jom.2020.0560
- Makarenko, I., Mazhnaya, A., Polonsky, M., Marcus, R., Bojko, M. J., Filippovych, S., Springer, S., Dvoriak, S., & Altice, F. L. (2016). Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine. Drug and Alcohol Dependence, 165, 213–220. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2016.06.011
- Molfenter, T., Brown, R., O’Neill, A., Kopetsky, E., & Toy, A. (2018). Use of telemedicine in addiction treatment: Current practices and organizational implementation characteristics. International Journal of Telemedicine and Applications, 2018, 3932643. https://doi.org/https://doi.org/10.1155/2018/3932643
- Nambiar, D., Agius, P. A., Stoové, M., Hickman, M., & Dietze, P. (2015). Cessation of injecting drug use: The effects of health service utilisation, drug use and demographic factors. Drug and Alcohol Dependence, 154, 208–213. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2015.06.037
- Nebhinani, N., Sarkar, S., Ghai, S., & Basu, D. (2012). Reasons for help-seeking and associated fears in subjects with substance dependence. Indian Journal of Psychological Medicine, 34(2), 153–158. https://doi.org/https://doi.org/10.4103/0253-7176.101784
- New country classifications by income level: 2019–2020. (2020). Retrieved April 27, 2020, from https://blogs.worldbank.org/opendata/new-country-classifications-income-level-2019-2020
- O’Brien, B. C., Harris, I. B., Beckman, T. J., Reed, D. A., & Cook, D. A. (2014). Standards for reporting qualitative research: A synthesis of recommendations. Academic Medicine, 89(9), 1245–1251. https://doi.org/https://doi.org/10.1097/ACM.0000000000000388
- Ozechowski, T. J., & Waldron, H. B. (2010). Assertive outreach strategies for narrowing the adolescent substance abuse treatment gap: Implications for research, practice, and policy. The Journal of Behavioral Health Services & Research, 37(1), 40–63. https://doi.org/https://doi.org/10.1007/s11414-008-9136-0
- Pasareanu, A. R., Opsal, A., Vederhus, J.-K., Kristensen, Ø., & Clausen, T. (2015). Quality of life improved following in-patient substance use disorder treatment. Health and Quality of Life Outcomes, 13(1), 35. https://doi.org/https://doi.org/10.1186/s12955-015-0231-7
- Patel, P., Kaiser, B. N., Meade, C. S., Giusto, A., Ayuku, D., & Puffer, E. (2020). Problematic alcohol use among fathers in Kenya: Poverty, people, and practices as barriers and facilitators to help acceptance. The International Journal on Drug Policy, 75, 102576. https://doi.org/https://doi.org/10.1016/j.drugpo.2019.10.003
- Polonsky, M., Azbel, L., Wickersham, J. A., Taxman, F. S., Grishaev, E., Dvoryak, S., & Altice, F. L. (2015). Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS. Drug and Alcohol Dependence, 148, 47–55. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2014.12.008
- Preston, L., Carroll, C., Gardois, P., Paisley, S., & Kaltenthaler, E. (2015). Improving search efficiency for systematic reviews of diagnostic test accuracy: An exploratory study to assess the viability of limiting to MEDLINE, EMBASE and reference checking. Systematic Reviews, 4, 82. https://doi.org/https://doi.org/10.1186/s13643-015-0074-7
- Rapp, R. C., Xu, J., Carr, C. A., Lane, D. T., Wang, J., & Carlson, R. (2006). Treatment barriers identified by substance abusers assessed at a centralized intake unit. Journal of Substance Abuse Treatment, 30(3), 227–235. https://doi.org/https://doi.org/10.1016/j.jsat.2006.01.002
- Rehm, J., Manthey, J., Shield, K. D., & Ferreira-Borges, C. (2019). Trends in substance use and in the attributable burden of disease and mortality in the WHO European Region, 2010-16. European Journal of Public Health, 29(4), 723–728. https://doi.org/https://doi.org/10.1093/eurpub/ckz064
- Rehm, J., Taylor, B., & Room, R. (2006). Global burden of disease from alcohol, illicit drugs and tobacco. Drug and Alcohol Review, 25(6), 503–513. https://doi.org/https://doi.org/10.1080/09595230600944453
- Rosenkranz, M., Kerimi, N., Takenova, M., Impinen, A., Mamyrov, M., Degkwitz, P., Zurhold, H., & Martens, M.-S. (2016). Assessment of health services for people who use drugs in Central Asia: Findings of a quantitative survey in Kazakhstan and Kyrgyzstan. Harm Reduction Journal, 13, 3. https://doi.org/https://doi.org/10.1186/s12954-016-0093-2
- Sabarinah. (2019). Use of drug treatment and rehabilitation services in Indonesia: Findings of the 2014 National Narcotic Survey. Asia-Pacific Journal of Public Health, 31(6), 548–558. https://doi.org/https://doi.org/10.1177/1010539519872343
- Sagbakken, M., Frich, J. C., & Bjune, G. (2008). Barriers and enablers in the management of tuberculosis treatment in Addis Ababa, Ethiopia: A qualitative study. BMC Public Health, 8(1), 11. https://doi.org/https://doi.org/10.1186/1471-2458-8-11
- Sarkar, S., Patra, B. N., & Kattimani, S. (2016). Substance use disorder and the family: An Indian perspective. Medical Journal of Dr. D.Y. Patil University, 9(1), 7–14. https://doi.org/https://doi.org/10.4103/0975-2870.172413
- Searching for and selecting studies. (2021). https://training.cochrane.org/handbook/current/chapter-04#section-4-6-4
- Sheeran, P., & Abraham, C. (1996). The health belief model. Predicting Health Behaviour, 2, 29–80.
- Sinha, T., Ranson, M. K., Chatterjee, M., Acharya, A., & Mills, A. J. (2006). Barriers to accessing benefits in a community-based insurance scheme: Lessons learnt from SEWA Insurance, Gujarat. Health Policy and Planning, 21(2), 132–142. https://doi.org/https://doi.org/10.1093/heapol/czj010
- Smith, M. K., Solomon, S. S., Cummings, D. A. T., Srikrishnan, A. K., Kumar, M. S., Vasudevan, C. K., McFall, A. M., Lucas, G. M., Celentano, D. D., & Mehta, S. H. (2018). Overlap between harm reduction and HIV service utilisation among PWID in India: Implications for HIV combination prevention. International Journal of Drug Policy, 57, 111–118. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.02.007
- Stoebner-Delbarre, A., & Aghi, M. B. (2013). A comparative study of perceptions on tobacco in vulnerable populations between India and France. Global Health Promotion, 20(4 Suppl), 82–89. https://doi.org/https://doi.org/10.1177/1757975913501209
- Strecher, V. J., & Rosenstock, I. M. (1997). The health belief model. In Ayers, S., Baum, A., McManus, C., Newman, S., WallSton, K., Weinman, J., West, R., (Eds.). Cambridge handbook of psychology, health and medicine (Vol. 113, p. 117). Cambridge, United Kingdom: Cambridge University Press.
- Sundararajan, R., Wyatt, M. A., Woolf-King, S., Pisarski, E. E., Emenyonu, N., Muyindike, W. R., Hahn, J. A., & Ware, N. C. (2015). Qualitative study of changes in alcohol use among HIV-infected adults entering care and treatment for HIV/AIDS in rural southwest Uganda. AIDS and Behavior, 19(4), 732–741. https://doi.org/https://doi.org/10.1007/s10461-014-0918-5
- Timko, C., Below, M., Schultz, N. R., Brief, D., & Cucciare, M. A. (2015). Patient and program factors that bridge the detoxification-treatment gap: A structured evidence review. Journal of Substance Abuse Treatment, 52, 31–39. https://doi.org/https://doi.org/10.1016/j.jsat.2014.11.009
- Tomori, C., Go, V. F., Tuan, L. N., Huong, N. M., Binh, N. T., Zelaya, C. E., Celentano, D. D., Dat, D. T., & Quan, V. M. (2014). “In their perception we are addicts”: Social vulnerabilities and sources of support for men released from drug treatment centers in Vietnam. The International Journal on Drug Policy, 25(5), 897–904. https://doi.org/https://doi.org/10.1016/j.drugpo.2014.04.012
- Tran, B. X., Boggiano, V. L., Nguyen, C. T., Nguyen, L. H., Le Nguyen, A. T., & Latkin, C. A. (2017). Barriers to accessing and using health insurance cards among methadone maintenance treatment patients in northern Vietnam. Substance Abuse Treatment, Prevention, and Policy, 12(1), 35. https://doi.org/https://doi.org/10.1186/s13011-017-0119-0
- Tran, B. X., Nguyen, L. H., Tran, T. T., & Latkin, C. A. (2018). Social and structural barriers for adherence to methadone maintenance treatment among Vietnamese opioid dependence patients. PloS One, 13(1), e0190941. https://doi.org/https://doi.org/10.1371/journal.pone.0190941
- Umar, N. A., Abubakar, I., Fordham, R., & Bachmann, M. (2012). Direct costs of pulmonary tuberculosis among patients receiving treatment in Bauchi State, Nigeria. The International Journal of Tuberculosis and Lung Disease, 16(6), 835–840. https://doi.org/https://doi.org/10.5588/ijtld.10.0774
- van der Pol, P., Liebregts, N., de Graaf, R., Korf, D. J., van den Brink, W., & van Laar, M. (2013). Facilitators and barriers in treatment seeking for cannabis dependence. Drug Alcohol Depend, 133(2), 776–780. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2013.08.011
- van Enst, W. A., Scholten, R. J. P. M., Whiting, P., Zwinderman, A. H., & Hooft, L. (2014). Meta-epidemiologic analysis indicates that MEDLINE searches are sufficient for diagnostic test accuracy systematic reviews. Journal of Clinical Epidemiology, 67(11), 1192–1199. https://doi.org/https://doi.org/10.1016/j.jclinepi.2014.05.008
- Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. PLoS Medicine, 4(10), e297. https://doi.org/https://doi.org/10.1371/journal.pmed.0040297
- Wunsch, H., Angus, D. C., Harrison, D. A., Collange, O., Fowler, R., Hoste, E. A. J., de Keizer, N. F., Kersten, A., Linde-Zwirble, W. T., Sandiumenge, A., & Rowan, K. M. (2008). Variation in critical care services across North America and Western Europe*. Critical Care Medicine, 36(10), 2787https://doi.org/https://doi.org/10.1097/CCM.0b013e318186aec8
- Zamudio-Haas, S., Mahenge, B., Saleem, H., Mbwambo, J., & Lambdin, B. H. (2016). Generating trust: Programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania. International Journal of Drug Policy, 30, 43–51. https://doi.org/https://doi.org/10.1016/j.drugpo.2016.01.012
- Zelenev, A., Shea, P., Mazhnaya, A., Rozanova, J., Madden, L., Marcus, R., & Altice, F. L. (2018). Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine. Drug and Alcohol Dependence, 190, 82–88. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.05.027
- Zewdu, S., Hanlon, C., Fekadu, A., Medhin, G., & Teferra, S. (2019). Treatment gap, help-seeking, stigma and magnitude of alcohol use disorder in rural Ethiopia. Substance Abuse Treatment, Prevention, and Policy, 14(1), 4. https://doi.org/https://doi.org/10.1186/s13011-019-0192-7
- Zubaran, C., & Foresti, K. (2009). Quality of life and substance use: Concepts and recent tendencies. Current Opinion in Psychiatry, 22(3), 281–286. https://doi.org/https://doi.org/10.1097/yco.0b013e328328d154